Science Corporation’s brain tech is worth $3.5 billion after new funding
Science Corporation’s brain tech is worth $3.5 billion after new funding
Science Corporation, the medical technology startup founded in 2021 by former Neuralink president Max Hodak, raised a $400 million Series D at a $3.5 billion valuation, with backers including Khosla Ventures, Y Combinator, and Tenet Healthcare. Its first product, PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision, is approved in Europe and available in Germany, and is now being trialled for Stargardt's disease. The company aims to bring the device to the US through the FDA's Humanitarian Device Exemption, while pursuing its founding goal of a bio-hybrid sensor combining cultured neurons and silicon, with initial human trials being designed with Yale neurosurgery professor Murat Günel.
Source: TechCrunch · AI · techcrunch.com